Thorsten Graef - 26 Feb 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Medical Officer
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
Issuer symbol
ARTV
Transactions as of
26 Feb 2025
Transactions value $
$0
Form type
4
Filing time
28 Feb 2025, 17:15:13 UTC
Previous filing
13 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Award $0 +60K +300% $0.00 80K 26 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.